Cargando…

Évolution des techniques de préparation des produits sanguins labiles (PSL) : inactivation des pathogènes dans les PSL

The techniques for inactivation of pathogens in labile blood products (LBP) would appear to be the new strategy which will permit us to increase transfusion safety in the face of the risks of transmission of pathogenic agents by LBP. Various methods are in the course of development or already valida...

Descripción completa

Detalles Bibliográficos
Autores principales: Naegelen, C., Isola, H., Dernis, D., Maurel, J.-P., Tardivel, R., Bois, S., Vignoli, C., Cazenave, J.-P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110575/
https://www.ncbi.nlm.nih.gov/pubmed/19443252
http://dx.doi.org/10.1016/j.tracli.2009.03.022
Descripción
Sumario:The techniques for inactivation of pathogens in labile blood products (LBP) would appear to be the new strategy which will permit us to increase transfusion safety in the face of the risks of transmission of pathogenic agents by LBP. Various methods are in the course of development or already validated and used in France. The latter only apply however to plasma or platelet concentrates. The mechanisms of action and the efficacy of inactivation and attenuation of pathogenic agents vary with the different techniques. Each of these constitutes a preparative procedure composed of unit steps which have to be fully mastered in order to ensure the quality and transfusion efficacy of the treated product.